The 10 analysts offering 12-month price forecasts for Sangamo Therapeutics Inc have a median target of 21.00, with a high estimate of 30.00 and a low estimate of 11.00. The median estimate represents a +85.02% increase from the last price of 11.35.
The current consensus among 12 polled investment analysts is to Buy stock in Sangamo Therapeutics Inc. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.31
Reporting Date Aug 11
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.